πŸ‡ΊπŸ‡Έ FDA
Patent

US 12391920

Models of tauopathy

granted A61KA61K48/0058A61K9/0019

Quick answer

US patent 12391920 (Models of tauopathy) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K48/0058, A61K9/0019